Printed on Mon Sep 26 2022 7:47:03 PM

Drug Administration approved for emergency use of Johnson's vaccine

Staff Correspondent
National
emergency use of Johnson's vaccine
The Department of Drug Administration has approved a vaccine for coronavirus produced in Belgium for emergency use in the country. A total of six ticks have been approved in the country.

A press release signed by the Director General of the Department of Drug Administration, Major General Mahbubur Rahman confirmed this information on Tuesday, June 15.

The application was submitted to the Drug Administration through MNC & H, Line Director, Department of Health, Ministry of Health and Family Welfare, for the issuance of the Covid-19 vaccine Emergency Use Authorization (EUA) produced by Johnson-Kliag International NB, Belgium.

In response to the application, the Department of Drug Administration evaluates the dossier (clinical part, CMSpart and regulatory status) of the vaccine.

The vaccine was approved for emergency use by the World Health Organization on March 12. On February 27, the U.S. Department of Drug Administration and on March 11, the European Union approved Johnson's vaccine for emergency use.

The vaccine is suitable for people 18 years of age and older. The one-dose vaccine, made in Belgium, will be given to people of a certain age in accordance with the government's deployment plan, the statement said. Its storage temperature is 2-6 degrees Celsius.

Voice TV/IA
Latest News